199 related articles for article (PubMed ID: 18281730)
1. Paliperidone: An improvement over risperidone?
Dopheide JA
Am J Health Syst Pharm; 2008 Mar; 65(5):401. PubMed ID: 18281730
[No Abstract] [Full Text] [Related]
2. Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.
Turkoz I; Bossie CA; Lindenmayer JP; Schooler N; Canuso CM
BMC Psychiatry; 2011 Feb; 11():21. PubMed ID: 21299844
[TBL] [Abstract][Full Text] [Related]
3. Paliperidone for treatment of schizophrenia.
Nussbaum AM; Stroup TS
Schizophr Bull; 2008 May; 34(3):419-22. PubMed ID: 18375569
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia.
Yang DS; Seong SJ; Yoon YR; Lim MS; Kwak KH; Lee SJ
J Psychopharmacol; 2014 Apr; 28(4):341-8. PubMed ID: 24346811
[TBL] [Abstract][Full Text] [Related]
5. [Paliperidone, risperidone].
Takeuchi K; Sanjo K; Sakai A
Nihon Rinsho; 2013 Apr; 71(4):654-9. PubMed ID: 23678595
[TBL] [Abstract][Full Text] [Related]
6. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Chung YC; Lee YH; Lee JH; Kim SY; Bae KY; Kim JM; Shin IS; Yoon JS
Int Clin Psychopharmacol; 2012 Sep; 27(5):267-74. PubMed ID: 22809972
[TBL] [Abstract][Full Text] [Related]
7. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.
Berwaerts J; Cleton A; Rossenu S; Talluri K; Remmerie B; Janssens L; Boom S; Kramer M; Eerdekens M
J Psychopharmacol; 2010 Jul; 24(7):1011-8. PubMed ID: 19825908
[TBL] [Abstract][Full Text] [Related]
8. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens.
Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197
[TBL] [Abstract][Full Text] [Related]
9. Paliperidone extended-release: does it have a place in antipsychotic therapy?
Gahr M; Kölle MA; Schönfeldt-Lecuona C; Lepping P; Freudenmann RW
Drug Des Devel Ther; 2011 Mar; 5():125-46. PubMed ID: 21448450
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone.
Perry R; Wolberg J; DiCrescento S
Am J Health Syst Pharm; 2012 Jan; 69(1):40-3. PubMed ID: 22180550
[TBL] [Abstract][Full Text] [Related]
11. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
Jones A
J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
[TBL] [Abstract][Full Text] [Related]
12. Paliperidone extended release.
Yang LP; Plosker GL
CNS Drugs; 2007; 21(5):417-25; discussion 426-7. PubMed ID: 17447829
[TBL] [Abstract][Full Text] [Related]
13. Treating residual insomnia in schizophrenia: examining the options.
Andrade C; Suresh Kumar PN
Acta Psychiatr Scand; 2013 Jan; 127(1):11. PubMed ID: 23240596
[No Abstract] [Full Text] [Related]
14. Paliperidone for schizophrenia.
Dolder C; Nelson M; Deyo Z
Am J Health Syst Pharm; 2008 Mar; 65(5):403-13. PubMed ID: 18281731
[TBL] [Abstract][Full Text] [Related]
15. Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.
Fu DJ; Bossie CA; Sliwa JK; Ma YW; Alphs L
Int Clin Psychopharmacol; 2014 Jan; 29(1):45-55. PubMed ID: 24113628
[TBL] [Abstract][Full Text] [Related]
16. Paliperidone extended release: in adolescents with schizophrenia.
Perry CM
Paediatr Drugs; 2012 Dec; 14(6):417-27. PubMed ID: 23050744
[TBL] [Abstract][Full Text] [Related]
17. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
Paulzen M; Orfanos S; Gründer G
Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
[No Abstract] [Full Text] [Related]
18. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent.
Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400
[TBL] [Abstract][Full Text] [Related]
19. Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation.
Kandasamy A
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E17-8. PubMed ID: 23037663
[No Abstract] [Full Text] [Related]
20. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study.
Gattaz WF; Campos JA; Lacerda AL; Henna E; Ruschel SI; Bressan RA; de Oliveira IR; Rocha FL; Grabowski HM; Sacomani E; Louzã MR; Quevedo J; Elkis H; Zorzetto Filho D; Périco Cde A; Lawson FL; Appolinário JC
Curr Med Res Opin; 2014 Apr; 30(4):695-709. PubMed ID: 24289141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
